BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38548092)

  • 1. Compound SJ-12 attenuates streptozocin-induced diabetic cardiomyopathy by stabilizing SERCA2a.
    Lou S; Zhu W; Yu T; Zhang Q; Wang M; Jin L; Xiong Y; Xu J; Wang Q; Chen G; Liang G; Hu X; Luo W
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167140. PubMed ID: 38548092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S; Asahi M; Takeda T; Otsu K; Taniguchi N; Miyoshi E; Suzuki K
    Glycobiology; 2010 Oct; 20(10):1217-26. PubMed ID: 20484118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
    Fricovsky ES; Suarez J; Ihm SH; Scott BT; Suarez-Ramirez JA; Banerjee I; Torres-Gonzalez M; Wang H; Ellrott I; Maya-Ramos L; Villarreal F; Dillmann WH
    Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R689-99. PubMed ID: 22874425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.
    Clark RJ; McDonough PM; Swanson E; Trost SU; Suzuki M; Fukuda M; Dillmann WH
    J Biol Chem; 2003 Nov; 278(45):44230-7. PubMed ID: 12941958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin Attenuates Cardiac Dysfunction in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Diabetic Cardiomyopathy.
    Lu J; Dai QM; Ma GS; Zhu YH; Chen B; Li B; Yao YY
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):367-379. PubMed ID: 28779372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy.
    Sulaiman M; Matta MJ; Sunderesan NR; Gupta MP; Periasamy M; Gupta M
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H833-43. PubMed ID: 20008278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside-Rb1 Improved Diabetic Cardiomyopathy through Regulating Calcium Signaling by Alleviating Protein O-GlcNAcylation.
    Qin L; Wang J; Zhao R; Zhang X; Mei Y
    J Agric Food Chem; 2019 Dec; 67(51):14074-14085. PubMed ID: 31793297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of high glucose-induced inflammation and fibrosis by a novel curcumin derivative prevents renal and heart injury in diabetic mice.
    Chen H; Yang X; Lu K; Lu C; Zhao Y; Zheng S; Li J; Huang Z; Huang Y; Zhang Y; Liang G
    Toxicol Lett; 2017 Aug; 278():48-58. PubMed ID: 28700904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous hydrogen sulphide ameliorates diabetic cardiomyopathy in rats by reversing disordered calcium-handling system in sarcoplasmic reticulum.
    Cheng YS; Dai DZ; Dai Y; Zhu DD; Liu BC
    J Pharm Pharmacol; 2016 Mar; 68(3):379-88. PubMed ID: 26968978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis.
    Kain V; Kumar S; Sitasawad SL
    Cardiovasc Diabetol; 2011 Nov; 10():97. PubMed ID: 22054019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR tyrosine kinase inhibition decreases cardiac remodeling and SERCA2a/NCX1 depletion in streptozotocin induced cardiomyopathy in C57/BL6 mice.
    Shah S; Akhtar MS; Hassan MQ; Akhtar M; Paudel YN; Najmi AK
    Life Sci; 2018 Oct; 210():29-39. PubMed ID: 30107170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathway.
    Han X; Zhou W; Zhang J; Tu Y; Wei J; Zheng R; Zhu J; Xu D; Ying H; Wu G; Shi Q; Liang G
    Int Immunopharmacol; 2023 Nov; 124(Pt B):110984. PubMed ID: 37757635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy.
    Torre E; Arici M; Lodrini AM; Ferrandi M; Barassi P; Hsu SC; Chang GJ; Boz E; Sala E; Vagni S; Altomare C; Mostacciuolo G; Bussadori C; Ferrari P; Bianchi G; Rocchetti M
    Cardiovasc Res; 2022 Mar; 118(4):1020-1032. PubMed ID: 33792692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteolin modulates SERCA2a via Sp1 upregulation to attenuate myocardial ischemia/reperfusion injury in mice.
    Hu Y; Zhang C; Zhu H; Wang S; Zhou Y; Zhao J; Xia Y; Li D
    Sci Rep; 2020 Sep; 10(1):15407. PubMed ID: 32958799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.
    Younce CW; Burmeister MA; Ayala JE
    Am J Physiol Cell Physiol; 2013 Mar; 304(6):C508-18. PubMed ID: 23302777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice.
    Yu M; Liu Y; Zhang B; Shi Y; Cui L; Zhao X
    Cardiovasc Pathol; 2015; 24(6):375-81. PubMed ID: 26164195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation.
    Zhang J; Wang G; Shi Y; Liu X; Liu S; Chen W; Ning Y; Cao Y; Zhao Y; Li M
    Cardiovasc Diabetol; 2024 May; 23(1):160. PubMed ID: 38715043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress.
    Zhang L; Hu C; Jin B; Bai B; Liao J; Jin L; Wang M; Zhu W; Wu X; Zheng L; Xu X; Jiang Y; Wang Y; He Y
    Cardiovasc Drugs Ther; 2024 Jun; 38(3):555-568. PubMed ID: 36662448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of advanced glycation endproduct (AGE) rescues against streptozotocin-induced diabetic cardiomyopathy: Role of autophagy and ER stress.
    Pei Z; Deng Q; Babcock SA; He EY; Ren J; Zhang Y
    Toxicol Lett; 2018 Mar; 284():10-20. PubMed ID: 29174818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.